A study spanning 12 years reveals that moderate adherence to a healthful pro-vegetarian diet significantly reduces mortality risks from cardiovascular disease and all causes among Spanish adults over 65.
Mesoblast wins long-awaited approval for cell therapy
Mesoblast’s stock surged on Thursday after the company won FDA approval for its twice-rejected graft-versus-host disease therapy. Remestemcel-L is the first mesenchymal stromal cell therapy